SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-22-009861
Filing Date
2022-04-14
Accepted
2022-04-13 19:01:11
Documents
69
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1316488
2 ex31-1.htm EX-31.1 13203
3 ex32-1.htm EX-32.1 6706
4 form10-k_001.jpg GRAPHIC 25432
5 form10-k_002.jpg GRAPHIC 22099
  Complete submission text file 0001493152-22-009861.txt   7059721

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE endv-20211231.xsd EX-101.SCH 57919
7 XBRL CALCULATION FILE endv-20211231_cal.xml EX-101.CAL 51997
8 XBRL DEFINITION FILE endv-20211231_def.xml EX-101.DEF 272915
9 XBRL LABEL FILE endv-20211231_lab.xml EX-101.LAB 485641
10 XBRL PRESENTATION FILE endv-20211231_pre.xml EX-101.PRE 368752
63 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1142575
Mailing Address 6320 CANOGA AVENUE 15TH FLOOR WOODLAND HILLS CA 91367
Business Address 6320 CANOGA AVENUE 15TH FLOOR WOODLAND HILLS CA 91367 (800) 489-4774
ENDONOVO THERAPEUTICS, INC. (Filer) CIK: 0001528172 (see all company filings)

IRS No.: 452552528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-55453 | Film No.: 22825656
SIC: 2834 Pharmaceutical Preparations